Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $22 Million - $24.9 Million
115,000 Added 255.56%
160,000 $33.9 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $3.75 Million - $4.13 Million
20,000 Added 80.0%
45,000 $8.66 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $3.19 Million - $5.08 Million
25,000 New
25,000 $5.06 Million
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $213,674 - $254,730
-1,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $202,620 - $241,650
1,500 New
1,500 $237,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.